Whole-Exome Sequencing Identifies Pathogenic Variants in TJP1 Gene Associated With Arrhythmogenic Cardiomyopathy
暂无分享,去创建一个
Silvio C. E. Tosatto | D. Corrado | D. Husser | G. Thiene | C. Basso | S. Tosatto | G. Vazza | L. Daliento | G. Minervini | M. Calore | J. P. van Tintelen | A. Postma | M. Perazzolo Marra | M. De Bortoli | A. Rampazzo | B. Bauce | I. Rigato | E. Mazzotti | Alessandra Lorenzon | G. Poloni | A. Cipriani | M. Ebert | R. Bariani | J. V. van Tintelen | Giovanni Minervini
[1] T. Wieland,et al. Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy , 2017, Circulation. Cardiovascular genetics.
[2] T. V. van Veen,et al. Refining the molecular organization of the cardiac intercalated disc , 2017, Cardiovascular research.
[3] D. Tester,et al. Whole exome sequencing with genomic triangulation implicates CDH2‐encoded N‐cadherin as a novel pathogenic substrate for arrhythmogenic cardiomyopathy , 2017, Congenital heart disease.
[4] R. Hauer,et al. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis , 2017, Cardiovascular research.
[5] M. Calore,et al. Arrhythmogenic right-ventricular cardiomyopathy: molecular genetics into clinical practice in the era of next generation sequencing , 2016, Journal of cardiovascular medicine.
[6] Monika Fuxreiter,et al. The Structure and Dynamics of Higher-Order Assemblies: Amyloids, Signalosomes, and Granules , 2016, Cell.
[7] Stefan L. Zimmerman,et al. Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations. , 2015, JACC. Cardiovascular imaging.
[8] M. Furuse,et al. ZO-1 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Involvement of ZO-1 in the Regulation of Cytoskeleton and Cell Shape , 2014, PloS one.
[9] Paco Hulpiau,et al. Mutations in the area composita protein αT-catenin are associated with arrhythmogenic right ventricular cardiomyopathy. , 2013, European heart journal.
[10] R. Hauer,et al. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.
[11] M. Ashworth,et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.
[12] R. Gourdie,et al. The perinexus: a new feature of Cx43 gap junction organization. , 2012, Heart rhythm.
[13] A. Lavie,et al. The Src Homology 3 Domain Is Required for Junctional Adhesion Molecule Binding to the Third PDZ Domain of the Scaffolding Protein ZO-1* , 2011, The Journal of Biological Chemistry.
[14] Andrew L. Lee,et al. Phosphorylation of a PDZ Domain Extension Modulates Binding Affinity and Interdomain Interactions in Postsynaptic Density-95 (PSD-95) Protein, a Membrane-associated Guanylate Kinase (MAGUK)* , 2011, The Journal of Biological Chemistry.
[15] Brian R. Anderson,et al. Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes , 2011, Circulation.
[16] R. Gourdie,et al. Connexin 43 connexon to gap junction transition is regulated by zonula occludens-1 , 2011, Molecular biology of the cell.
[17] Q. Gong,et al. Solution structure of the second PDZ domain of Zonula Occludens 1 , 2011, Proteins.
[18] M. Mann,et al. System-Wide Temporal Characterization of the Proteome and Phosphoproteome of Human Embryonic Stem Cell Differentiation , 2011, Science Signaling.
[19] R. Gourdie,et al. ZO-1 determines adherens and gap junction localization at intercalated disks. , 2011, American journal of physiology. Heart and circulatory physiology.
[20] Mingjie Zhang,et al. Extensions of PDZ domains as important structural and functional elements , 2010, Protein & Cell.
[21] A. Lavie,et al. Insights into Regulated Ligand Binding Sites from the Structure of ZO-1 Src Homology 3-Guanylate Kinase Module* , 2010, The Journal of Biological Chemistry.
[22] S. Brunak,et al. Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis , 2010, Science Signaling.
[23] I. V. Van Gelder,et al. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. , 2009, Heart rhythm.
[24] Dudley J Pennell,et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.
[25] T. Noda,et al. Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. , 2008, Molecular biology of the cell.
[26] Sean Connors,et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.
[27] N. Severs,et al. Gap junction remodelling in human heart failure is associated with increased interaction of connexin43 with ZO-1 , 2007, Cardiovascular research.
[28] P. Syrris,et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. , 2006, American journal of human genetics.
[29] Maurizio Schiavon,et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.
[30] G. Danieli,et al. Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.
[31] Gian Antonio Danieli,et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.
[32] Walter Birchmeier,et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.
[33] G. Danieli,et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.
[34] K. Irie,et al. alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin. , 2001, Molecular biology of the cell.
[35] D. Stephan,et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.
[36] G. Danieli,et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[37] A. Crosby,et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.
[38] B. Giepmans,et al. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein , 1998, Current Biology.
[39] M. Itoh,et al. Involvement of ZO-1 in Cadherin-based Cell Adhesion through Its Direct Binding to α Catenin and Actin Filaments , 1997, The Journal of cell biology.
[40] M. Sudol,et al. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] G. Thiene,et al. Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.
[42] D. Corrado,et al. Right ventricular cardiomyopathy and sudden death in young people. , 1988, The New England journal of medicine.